NCT02262858View on ClinicalTrials.gov

Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

October 31, 2005

Conditions
Healthy
Interventions
DRUG

Telmisartan and HCTZ

DRUG

Telmisartan

DRUG

HCTZ

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY